Neuroleptics and Psychic Indifference: A Review

Carlsson A. , Lindquist M. . Effect of chlorpromazine and haloperidol on formation of 3-methoxy-tyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 1963; 20: 140–4

Van Rossum J.M. . The significance of dopamine receptor blockades in the mechanism of action of neuroleptic drugs. Arch Int Pharmacodyn Ther 1966; 60: 492–4

Anden N.E. , Butcher S.G. , Corrodi H. , Fuxe K. , Ungerstedt U. . Receptor activity and turnover of dopamine and noradrenalne after neuroleptics. Eur J Pharmacol 1970; 11: 303

Seeman P. . Brain dopamine receptors. Pharmacol Rev 1980; 32: 229–313

Johnstone E.C. , Crow T.J. , Frith C.D. , Carney M.W.P. , Price J.S. . Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet 1978; i: 848–51

Snyder S.H. . The dopamine hypothesis of schizophrenia; focus on the dopamine receptor. Am J Psychiatry 1976; 133; 197–202

Bell D.S. . The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry 1983; 29: 35–40

Lieberman J.A. , Kane J.M. , Alvir J. . Provocative tests with psychostimulant drugs. Psychopharmacology 1987; 91: 415–33

Randrup A. , Munkvad I. . On the role of dopamine in the amphetamine excitatory response. Nature 1966; 211: 540

Crow T.J. . The dopamine hypothesis survives but there must be a way ahead. Br J Psychiatry 1987; 151: 460–5

Wong D.F. , Wagner H.N. , Cune L.E. Positron emission tomography reveals elevated D₂ dopamine receptors in drug naive schizophrenics. Science 1986; 234: 1158–63

Farde L. , Wiesel F. , Hall H. , Stone-Elander S. , Sedvall G. . D₂ dopamine receptor characteristics in human controls and drug naive schizophrenic patients. J Psychopharmac 1987; 1: abstracts.

Stevens J.R. . An anatomy of schizophrenia. Arch Gen Psychiatry 1973; 29: 177–89

Beninger R.J. . The role of dopamine in locomotor activity and learning. Brain Res Rev 1983; 6: 173–96

Bannon M.J. , Roth R.H. . Pharmacology of mesocortical dopamine neurones. Pharmacol Rev 1983; 35: 53–68

Meltzer H.Y. , Stahl S. . The dopamine hypothesis of schizophrenia; a review. Schizophr Buil 1976; 2: 19

Healy D. . Rhythm and Blues. Psychopharmacology 1987; 93: 271–85

Bowers M.B. , Heninger B.R. . Cerebrospinal fluid HVA patterns during neuroleptic treatment. Psychiatry Res 1981; 4: 285–290

Pickar D. . Neuroleptics, dopamine and schizophrenia Psychiat Clin North Am 1986; 9: 35–40

Miller R. . The time course of neuroleptic therapy for psychosis: role of learning processes and implications for concepts of psychotic illness. Psychopharmacology 1987; 92: 405–15

Chiodo L.A. , Bunney B.S. . Typical and atypical neuroleptics; differential effects of chronic administration on the activity of A-9 and A-10 mid brain dopamine neurons. J Neurosci 1983; 3: 1607–19

Joseph M.H. , Frith C.D. , Waddington J.L. . Dopaminergic mechanisms and cognitive deficits in schizophrenia. Psychopharmacology 1979; 63: 273–80

Ridley R.N. , Baker H.F. . Is there a relationship between social isolation, cognitive inflexibility and behavioural stereotype? An analysis of the effects of amphetamine in the marmoset. In Ethopharmacology; primate models of neuropsychiatric disorders. New York: Alan R Liss, 1983: 101–35

McKenna P.J. . Pathology, phenomenology and the dopamine hypothesis of schizophrenia. Br J Psychiatry 1987; 151: 288–301

Crow T.J. . Positive and negative schizophrenic symptoms and the role of dopamine Br J Psychiatry 1980; 137: 383–6

Venables P.H. , Wing J.K. . Level of arousal and sub-classification of schizophrenia. Arch Gen Psychiatry 1962; 7: 114–19

Hemsley D.R. . What have cognitive deficits got to do with schizophrenic symptoms? Br J Psychiatry 1977, 130: 167–73

Bleuler M. . The schizophrenic disorders: longterm patient and family studies (trans Clemens SM) Newhaven and London University Press, 1978

Huber G. , Gross G. , Schuttla R. , Linz M. . Longitudinal studies of schizophrenic patients Schizophr Bull 1980; 6: 592–605

Ciompi L. . The natural history of schizophrenia in the long term Br J Psychiatry 1980; 136: 413–20

Kay S.R. , Opler L.A. . The positive and negative dimensions in schizophrenia: its validity and significance Psychiatr Dev 1987; 5: 79–103

Liddle P.F. . The symptoms of chronic schizophrenia: a reexamination of the positive/negative dichotomy Br J Psychiatry 1987; 151: 145–51

Kolakowska T. , Williams A.O. , Ardern M. Schizophrenia with good and poor outcome. Br J Psychiatry 1985; 146: 229–46

Waddington J.L. , Youssef A.J. . Late onset involuntary movements of chronic schizophrenia: relationship of ‘tardive’ dyskinesia to intellect impairment and negative symptoms. Br J Psychiatry 1986; 149: 616–20

Murray R.M. , Lewis S.W. , Revely A.M. . Towards an aetiological classification of schizophrenia Lancet 1984; 1023–1026

Strauss J.S. , Kokes R.F. , Klormann R. , Sacksteder J.L. . Premorbid adjustment in schizophrenia; concepts, measures and implications Schizophr Bull 1977; 3: 182–5

Tantam D. . Schizophrenic defect. Br J Psychiatry 1983; 143: 83–4

Kirkpatrick B. , Johnson M. , McGuire K. , Fletcher R.H. . Confounding and the dementia of schizophrenia Psychiatry Res 1986; 19: 225–231

Davison K. . Schizophrenic-like psychoses associated with organic cerebral disorders; a review Psychiatr Dev 1983; 1: 1–34

Johnson D.A.W. . Studies of depressive symptoms in schizophrenia Br J Psychiatry 1981; 139: 89–101

Grau B.W. , Mueser K.T. , Lewine R.J. . Measurement of negative symptoms Schizophr Bull 1986; 12: 7–11

Frith C.D. . The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action. Psychol Med 1987; 17: 631–48

Allen H.A. . Positive and negative symptoms and the thematic organisation of schizophrenic speech. Br J Psychiatry 1984; 144: 611–17

Green M. , Walker E. . Attentional performance and positive and negative symptoms of schizophrenia. J Nerv Ment Disord 1981; 139: 204–8

Silverstone T. . Dopamine in manic depressive illness J Affect Dis 1985; 8: 225–231

Healy D. , Williams J.M.G. . Moods, misattributions and mania. Psychiatr Dev 1989; 7: 49–70

Snyder S.H. . Schizophrenia. Lancet 1982; 970–973

Swazey J.P. . Chlorpromazine in psychiatry Cambridge, Mass: MIT Press, 1974.

Kalinowski L.B. , Hoch P.H. . Somatic treatments in psychiatry. New York: Grune & Stratton, 1961

May P.R. , Van Putten T. , Yale C. Predicting individual responses to drug treatment in schizophrenia: a test dose model. J Nerv Ment Dis 1976; 162: 177–83

Healy D. . The structure of psychopharmacological revolutions Psychiatr Dev 1987; 5: 358–81

Baldesarrini R. . Drugs used in the treatment of psychoses. In: Gilman A.G. , Goodman L.S. , Gilman A. , eds. The pharmacological basis of therapeutics, 6th edn. Basingstoke: Macmillan, 1980: 395–418

Paykel E.S. . Life events, social support and psychiatric disorder. In: Sarason I.G. , Sarason B.R. , eds. Social support; theory, research and applications. The Hague: Martinus Nijhoff, 1985: 321–47

Vaughan C. , Leff J.P. . The influence of family and social factors on the course of psychiatric illness; a comparison of schizophrenic and depressed neurotic patients Br J Psychiatry 1976; 15: 147–65

Healy D. . Schizophrenia: basic, reactive, release and defect processes. Royal Society of Medicine, Mental Health Foundation Essay Prize, 1989 (available on request)

Sacks M. , Carpenter W. , Strauss J. . Recovery from delusions. Arch Gen Psychiatry 1974; 30: 117–20

Rudden N. , Gilmore M. , Francis A. . Delusions; when to confront the facts of life. Am J Psychiatry 1982; 139: 99–132

McKenna P.J. . Disorders with overvalued ideas. Br J Psychiatry 1984; 145: 579–85